Ikarian Capital, LLC Morphic Holding, Inc. Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$26.01 - $48.69 $1.19 Million - $2.23 Million	45,873 New	45,873 $1.73 Million
Q2 2021 Aug 16, 2021	SELL	$45.13 - $64.99 $2.25 Million - $3.24 Million	-49,925 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$29.77 - $84.85 $13.9 Million - $39.6 Million	-466,838 Reduced 90.34%	49,925 $3.16 Million
Q4 2020 Feb 12, 2021	BUY	$25.66 - $34.55 $13.3 Million - $17.9 Million	516,763 New	516,763 $17.3 Million

142

37.9M

13.5K

190K

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.31B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.